Search

everythinglearnresearchcommunity

for

Search:↓

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

Baricitinib is effective and safe for treating severe alopecia areata.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

Topical calcipotriol may help treat alopecia areata, especially in those with low vitamin D.

1% anthralin ointment is effective and safe for treating severe alopecia areata in children.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Abrocitinib may help treat alopecia areata effectively with mild side effects.

JAK inhibitors help hair regrowth in alopecia areata but have a high risk of side effects.

Winter-onset alopecia areata patients are more likely to regrow hair within a year compared to spring-onset patients.

Traditional treatment for pediatric alopecia areata is most effective and should be first choice.

Oral tofacitinib may be an effective and tolerable treatment for some people with severe alopecia areata.

Baricitinib helps improve hair growth in severe alopecia, with better results in less severe cases and higher doses working faster.

Baricitinib effectively reduces hair loss in alopecia areata and is well-tolerated.

Both tofacitinib and ruxolitinib are effective and tolerable for treating alopecia areata.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Etrasimod is safe but not effective for severe alopecia areata, though it may help milder cases.

Baricitinib is more effective than methotrexate for severe alopecia areata.

Baricitinib is effective for treating severe alopecia areata in Japanese patients, but long-term safety needs more study.

JAK inhibitors effectively regrow hair in children with alopecia areata and are safe to use.

Baricitinib is effective for severe alopecia areata but has some side effects.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Hair regrowth from severe alopecia areata treatment with baricitinib can vary, with faster results in those with shorter hair loss duration.

Ritlecitinib shows promise for hair regrowth in alopecia areata patients.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

Dexamethasone mini-pulse therapy is effective for alopecia areata but less effective for those with early onset or hypothyroidism.

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

JAK inhibitors effectively improve hair regrowth in alopecia areata with an acceptable safety profile.

Weekly azathioprine pulse is a better alternative to corticosteroids for treating alopecia areata due to fewer side effects.

Treat alopecia areata with personalized plans, using corticosteroids for mild cases and Janus Kinase inhibitors for severe cases, while also offering psychological support.

COVID-19 vaccines may rarely worsen hair loss in people with severe alopecia, but the benefits of vaccination still outweigh this risk.